Exploring Oral Therapy with Dr. Bernard Ravina of Vima Therapeutics

Julie sits down with Dr. Bernard Ravina, CEO and founder of Vima Therapeutics. His company is developing a drug that looks promising in helping those with dystonia. Vima Therapeutic websiteVima Therapeutics teamSite for current Phase 2 dystonia study into first oral medication. The study is named "Stride Dystonia"Survey done with the Dystonia Medical Research Foundation (DMRF).  Support the showThe information shared in this podcast is not intended to diagnose. recommend nor treat medical conditions. We are not licensed medical professionals and do not take the place of your team of medical professionals. You can find us here: Julie Bergfeld - [email protected] and juliebergfeld.com (@juliebergfeldcoaching) and JoJo Fraser - [email protected]